B
Benjamin D.L. Li
Researcher at LSU Health Sciences Center Shreveport
Publications - 63
Citations - 2397
Benjamin D.L. Li is an academic researcher from LSU Health Sciences Center Shreveport. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 27, co-authored 63 publications receiving 2280 citations. Previous affiliations of Benjamin D.L. Li include Louisiana State University & Yale University.
Papers
More filters
Journal ArticleDOI
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
Jesus Esquivel,Robert P. Sticca,Paul H. Sugarbaker,Edward A. Levine,Tristan D. Yan,Richard B. Alexander,Dario Baratti,David L. Bartlett,R. Barone,P. Barrios,S. Bieligk,P. Bretcha-Boix,C. K. Chang,Francis Chu,Quyen D. Chu,Steven A. Daniel,E. de Bree,M. Deraco,L. Dominguez-Parra,Dominique Elias,R. Flynn,Jason M. Foster,A. Garofalo,François Noël Gilly,Olivier Glehen,A. Gomez-Portilla,L. Gonzalez-Bayon,Santiago González-Moreno,M. Goodman,Vadim Gushchin,Nader Hanna,Jens Hartmann,Lawrence E. Harrison,R. Hoefer,John M. Kane,D. Kecmanovic,Scott T. Kelley,J. Kuhn,J. LaMont,Julie R. Lange,Benjamin D.L. Li,Brian L. Loggie,Haile Mahteme,Gary N. Mann,Robert C.G. Martin,R. A. Misih,Brendan Moran,David L. Morris,L. Onate-Ocana,Nicholas J. Petrelli,G. Philippe,James F. Pingpank,A. Pitroff,Pompiliu Piso,M. Quinones,Lee B. Riley,L. Rutstein,S. Saha,S. Alrawi,Armando Sardi,Schlomo Schneebaum,Perry Shen,David Shibata,J. Spellman,Alexander Stojadinovic,John H. Stewart,J. Torres-Melero,Todd M Tuttle,Victor J. Verwaal,J. Villar,Neal W. Wilkinson,Rami Younan,H.J. Zeh,F.A.N. Zoetmulder,Gilbert Sebbag +74 more
TL;DR: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin : a consensus statement.
Journal ArticleDOI
Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States
Kiran K. Turaga,Edward A. Levine,Robert M. Barone,Robert P. Sticca,Nicholas J. Petrelli,Laura A. Lambert,Garrett M. Nash,Michael A. Morse,R. Adbel-Misih,H.R. Alexander,F. Attiyeh,David L. Bartlett,A. Bastidas,T. Blazer,Quyen D. Chu,K. Y. Chung,L. Dominguez-Parra,N. J. Espat,Jason M. Foster,Keith Fournier,Reynaldo Garcia,Michael D. Goodman,Nader Hanna,Lawrence E. Harrison,Richard A. Hoefer,Matthew P. Holtzman,John M. Kane,Daniel M. Labow,Benjamin D.L. Li,Andrew M. Lowy,Paul F. Mansfield,E. Ong,Colette R. Pameijer,James F. Pingpank,M. Quinones,Richard E. Royal,George I. Salti,Armando Sardi,Perry Shen,Joseph J. Skitzki,J. Spellman,John H. Stewart,Jesus Esquivel +42 more
TL;DR: This recommendation on a standardized delivery of HIPEC in patients with colorectal cancer represents an important first step in enhancing research in this field and studies directed at maximizing the efficacy of each of the key elements will need to follow.
Journal Article
Insulin-like Growth Factors and Breast Cancer Risk in Chinese Women
Herbert Yu,Fan Jin,Xiao-Ou Shu,Benjamin D.L. Li,Qi Dai,Jia Rong Cheng,Hans J. Berkel,Wei Zheng +7 more
TL;DR: It is confirmed that high circulating levels of IGF-I are associated with elevated risk of breast cancer and that IGFBP-3 was positively associated with breast cancer risk in Chinese women.
Journal ArticleDOI
Free insulin-like growth factor-I and breast cancer risk.
Benjamin D.L. Li,M. Javad Khosravi,Hans J. Berkel,Anastasia Diamandi,Mark A. Dayton,Mylinh Smith,Herbert Yu,Herbert Yu +7 more
TL;DR: The findings of this study suggest that measuring free IGF‐I in circulation is more useful than measuring total IGF-I with respect to evaluation of an association between IGF‐i and breast cancer risk.
Journal ArticleDOI
High Chemokine Receptor CXCR4 Level in Triple Negative Breast Cancer Specimens Predicts Poor Clinical Outcome
TL;DR: Patients whose tumors had high CXCR4 overexpression had a significantly higher incidence of cancer recurrence and cancer-related death than those in the low CX CR4 group.